These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 28243834

  • 1. Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage.
    Ji B, Zhou F, Han L, Yang J, Fan H, Li S, Li J, Zhang X, Wang X, Chen X, Xu Y.
    Transl Stroke Res; 2017 Aug; 8(4):334-340. PubMed ID: 28243834
    [Abstract] [Full Text] [Related]

  • 2. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
    Ma Y, Li L, Kong L, Zhu Z, Zhang W, Song J, Chang J, Du G.
    Biomed Res Int; 2018 Aug; 2018():8943210. PubMed ID: 29850586
    [Abstract] [Full Text] [Related]

  • 3. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
    Teng F, Beray-Berthat V, Coqueran B, Lesbats C, Kuntz M, Palmier B, Garraud M, Bedfert C, Slane N, Bérézowski V, Szeremeta F, Hachani J, Scherman D, Plotkine M, Doan BT, Marchand-Leroux C, Margaill I.
    Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
    [Abstract] [Full Text] [Related]

  • 4. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
    Cai Y, Liu X, Chen W, Wang Z, Xu G, Zeng Y, Ma Y.
    Exp Neurol; 2015 Apr; 266():120-6. PubMed ID: 25708985
    [Abstract] [Full Text] [Related]

  • 5. Effect of blood pressure on early neurological deterioration of acute ischemic stroke patients with intravenous rt-PA thrombolysis may be mediated through oxidative stress induced blood-brain barrier disruption and AQP4 upregulation.
    He Y, Yang Q, Liu H, Jiang L, Liu Q, Lian W, Huang J.
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104997. PubMed ID: 32689627
    [Abstract] [Full Text] [Related]

  • 6. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y, Sharma VK, Robinson T, Lindley RI, Chen X, Kim JS, Lavados P, Olavarría V, Arima H, Fuentes S, Nguyen HT, Lee TH, Parsons MW, Levi C, Demchuk AM, Bath PM, Broderick JP, Donnan GA, Martins S, Pontes-Neto OM, Silva F, Pandian J, Ricci S, Stapf C, Woodward M, Wang J, Chalmers J, Anderson CS, ENCHANTED investigators.
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [Abstract] [Full Text] [Related]

  • 7. Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.
    Schellinger PD, Alexandrov AV, Barreto AD, Demchuk AM, Tsivgoulis G, Kohrmann M, Alleman J, Howard V, Howard G, Alexandrov AW, Brandt G, Molina CA, CLOTBUSTER Investigators.
    Int J Stroke; 2015 Oct; 10(7):1141-8. PubMed ID: 26120902
    [Abstract] [Full Text] [Related]

  • 8. Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
    Muhammad S, Planz O, Schwaninger M.
    Cerebrovasc Dis Extra; 2016 Oct; 6(2):50-9. PubMed ID: 27560521
    [Abstract] [Full Text] [Related]

  • 9. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH.
    JAMA; 1995 Oct 04; 274(13):1017-25. PubMed ID: 7563451
    [Abstract] [Full Text] [Related]

  • 10. Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.
    Simpkins AN, Dias C, Leigh R, National Institutes of Health Natural History of Stroke Investigators.
    Stroke; 2016 Sep 04; 47(9):2405-8. PubMed ID: 27462115
    [Abstract] [Full Text] [Related]

  • 11. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X, Hu HT, Liu S, Sun YH, Gao X.
    Neurol Res; 2015 Apr 04; 37(4):352-8. PubMed ID: 25297471
    [Abstract] [Full Text] [Related]

  • 12. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
    Salam KA, Ummer K, Pradeep Kumar VG, Noone ML.
    Int J Stroke; 2014 Jun 04; 9(4):426-8. PubMed ID: 23981667
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
    Yong M, Diener HC, Kaste M, Mau J.
    Cerebrovasc Dis; 2007 Jun 04; 24(4):349-54. PubMed ID: 17690547
    [Abstract] [Full Text] [Related]

  • 14. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Devlin TG, Lopes DK, Reddy V, du Mesnil de Rochemont R, Jahan R, SWIFT PRIME Investigators.
    Int J Stroke; 2015 Apr 04; 10(3):439-48. PubMed ID: 25777831
    [Abstract] [Full Text] [Related]

  • 15. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
    Saqqur M, Shuaib A, Alexandrov AV, Sebastian J, Khan K, Uchino K.
    Int J Stroke; 2015 Oct 04; 10(7):1087-92. PubMed ID: 26332252
    [Abstract] [Full Text] [Related]

  • 16. The rtPA increases MMP-9 activity in serum during ischaemic stroke.
    Gołąb P, Boguszewska-Czubara A, Kiełbus M, Kurzepa J.
    Neurol Neurochir Pol; 2014 Oct 04; 48(5):309-14. PubMed ID: 25440008
    [Abstract] [Full Text] [Related]

  • 17. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M, Furie KL, Koroshetz WJ, Lee H, Barron M, Lederer M, Wang X, Zhu M, Sorensen AG, Lo EH, Kelly PJ.
    Neurology; 2006 May 23; 66(10):1550-5. PubMed ID: 16717217
    [Abstract] [Full Text] [Related]

  • 18. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.
    Lawson TR, Brown IE, Westerkam DL, Blackhurst DW, Sternberg S, Leacock R, Nathaniel TI.
    Restor Neurol Neurosci; 2015 May 23; 33(3):301-8. PubMed ID: 25698111
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.